ArticleArteriosclerosis, thrombosis, and vascular biology2017
Sox10
Open access · bronzeAbstract read
In one paragraph
Article in Arteriosclerosis, thrombosis, and vascular biology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 25 citations in OpenAlex.
- Stem cell activation in organ culture reveals novel transcriptional programs underlying metabolic, fibrotic, vascular, and immune dysregulation in uterine leiomyomas.Frontiers in cell and developmental biology · 2026Article
- Zebrafish arterial valve development occurs through direct differentiation of second heart field progenitors.Cardiovascular research · 2025Article
- GNAQ/GNA11-Related Benign and Malignant Entities-A Common Histoembriologic Origin or a Tissue-Dependent Coincidence.Cancers · 2024Review
- Human intermediate prostate cancer stem cells contribute to the initiation and development of prostate adenocarcinoma.Stem cell research & therapy · 2024Article
- Oligodendrocyte-derived laminin-γ1 regulates the blood-brain barrier and CNS myelination in mice.Cell reports · 2024Article
- A closer look into the cellular and molecular biology of myoepithelial cells across various exocrine glands.The ocular surface · 2024Review
- Brain heterotopia formation by ciliopathic breakdown of neuroepithelial and blood-cerebrospinal fluid barriers.Brain pathology (Zurich, Switzerland) · 2023Article
- Neuro-mesodermal assembloids recapitulate aspects of peripheral nervous system development in vitro.Stem cell reports · 2023Article
- SM22α Deletion Contributes to Neurocognitive Impairment in Mice through Modulating Vascular Smooth Muscle Cell Phenotypes.International journal of molecular sciences · 2023Article
- Type II collagen-positive progenitors are important stem cells in controlling skeletal development and vascular formation.Bone research · 2022Article
- Nicotine Neurotoxicity Involves Low Wnt1 Signaling in Spinal Locomotor Networks of the Postnatal Rodent Spinal Cord.International journal of molecular sciences · 2021Article
- Neural crest-like stem cells for tissue regeneration.Stem cells translational medicine · 2021Review
- Macrophage-derived MMP-8 determines smooth muscle cell differentiation from adventitia stem/progenitor cells and promotes neointima hyperplasia.Cardiovascular research · 2020Article
- Reporting Sex and Sex Differences in Preclinical Studies.Arteriosclerosis, thrombosis, and vascular biology · 2018Article
- Vascular Development.Arteriosclerosis, thrombosis, and vascular biology · 2018Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors at 4 institutions in 2 countries.
Dong WangFrom the Department of Bioengineering (D.W., F.W., A.W., S.L.) and School of Optometry and Vision Science Graduate Program (D.W., G.J.K., T.T., L.C., X.G.), University of California, Berkeley; Department of Bioengineering (D.W., H.Y., S.L.) and Department of Medicine (S.L.), University of California, Los Angeles; The Second Xiangya Hospital of Central South University (H.Y.); Surgical Bioengineering Laboratory, Department of Surgery, School of Medicine, University of California, Davis (A.W.); and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine (A.S.M).
Fan WuFrom the Department of Bioengineering (D.W., F.W., A.W., S.L.) and School of Optometry and Vision Science Graduate Program (D.W., G.J.K., T.T., L.C., X.G.), University of California, Berkeley; Department of Bioengineering (D.W., H.Y., S.L.) and Department of Medicine (S.L.), University of California, Los Angeles; The Second Xiangya Hospital of Central South University (H.Y.); Surgical Bioengineering Laboratory, Department of Surgery, School of Medicine, University of California, Davis (A.W.); and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine (A.S.M).
Haoyong YuanFrom the Department of Bioengineering (D.W., F.W., A.W., S.L.) and School of Optometry and Vision Science Graduate Program (D.W., G.J.K., T.T., L.C., X.G.), University of California, Berkeley; Department of Bioengineering (D.W., H.Y., S.L.) and Department of Medicine (S.L.), University of California, Los Angeles; The Second Xiangya Hospital of Central South University (H.Y.); Surgical Bioengineering Laboratory, Department of Surgery, School of Medicine, University of California, Davis (A.W.); and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine (A.S.M).
Aijun WangFrom the Department of Bioengineering (D.W., F.W., A.W., S.L.) and School of Optometry and Vision Science Graduate Program (D.W., G.J.K., T.T., L.C., X.G.), University of California, Berkeley; Department of Bioengineering (D.W., H.Y., S.L.) and Department of Medicine (S.L.), University of California, Los Angeles; The Second Xiangya Hospital of Central South University (H.Y.); Surgical Bioengineering Laboratory, Department of Surgery, School of Medicine, University of California, Davis (A.W.); and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine (A.S.M).
Gyeong Jin KangFrom the Department of Bioengineering (D.W., F.W., A.W., S.L.) and School of Optometry and Vision Science Graduate Program (D.W., G.J.K., T.T., L.C., X.G.), University of California, Berkeley; Department of Bioengineering (D.W., H.Y., S.L.) and Department of Medicine (S.L.), University of California, Los Angeles; The Second Xiangya Hospital of Central South University (H.Y.); Surgical Bioengineering Laboratory, Department of Surgery, School of Medicine, University of California, Davis (A.W.); and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine (A.S.M).
Tan TruongFrom the Department of Bioengineering (D.W., F.W., A.W., S.L.) and School of Optometry and Vision Science Graduate Program (D.W., G.J.K., T.T., L.C., X.G.), University of California, Berkeley; Department of Bioengineering (D.W., H.Y., S.L.) and Department of Medicine (S.L.), University of California, Los Angeles; The Second Xiangya Hospital of Central South University (H.Y.); Surgical Bioengineering Laboratory, Department of Surgery, School of Medicine, University of California, Davis (A.W.); and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine (A.S.M).
Lu ChenFrom the Department of Bioengineering (D.W., F.W., A.W., S.L.) and School of Optometry and Vision Science Graduate Program (D.W., G.J.K., T.T., L.C., X.G.), University of California, Berkeley; Department of Bioengineering (D.W., H.Y., S.L.) and Department of Medicine (S.L.), University of California, Los Angeles; The Second Xiangya Hospital of Central South University (H.Y.); Surgical Bioengineering Laboratory, Department of Surgery, School of Medicine, University of California, Davis (A.W.); and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine (A.S.M).
Andrew S McCallionFrom the Department of Bioengineering (D.W., F.W., A.W., S.L.) and School of Optometry and Vision Science Graduate Program (D.W., G.J.K., T.T., L.C., X.G.), University of California, Berkeley; Department of Bioengineering (D.W., H.Y., S.L.) and Department of Medicine (S.L.), University of California, Los Angeles; The Second Xiangya Hospital of Central South University (H.Y.); Surgical Bioengineering Laboratory, Department of Surgery, School of Medicine, University of California, Davis (A.W.); and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine (A.S.M).
Xiaohua GongFrom the Department of Bioengineering (D.W., F.W., A.W., S.L.) and School of Optometry and Vision Science Graduate Program (D.W., G.J.K., T.T., L.C., X.G.), University of California, Berkeley; Department of Bioengineering (D.W., H.Y., S.L.) and Department of Medicine (S.L.), University of California, Los Angeles; The Second Xiangya Hospital of Central South University (H.Y.); Surgical Bioengineering Laboratory, Department of Surgery, School of Medicine, University of California, Davis (A.W.); and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine (A.S.M).
Song LiFrom the Department of Bioengineering (D.W., F.W., A.W., S.L.) and School of Optometry and Vision Science Graduate Program (D.W., G.J.K., T.T., L.C., X.G.), University of California, Berkeley; Department of Bioengineering (D.W., H.Y., S.L.) and Department of Medicine (S.L.), University of California, Los Angeles; The Second Xiangya Hospital of Central South University (H.Y.); Surgical Bioengineering Laboratory, Department of Surgery, School of Medicine, University of California, Davis (A.W.); and McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University School of Medicine (A.S.M). songli@ucla.edu.
Central South University · CNUniversity of California, Davis · USUniversity of California, Los Angeles · USSecond Xiangya Hospital of Central South University · CN
Funding
Cataracts, Connexin Mutants and Genetic ModifiersR01EY013849 · NEI · UNIVERSITY OF CALIFORNIA BERKELEY · PI Xiaohua Gong · 2002 to 2026
$8.2MDevelopment of a Neuronal Regulatory LexiconR01NS062972 · NINDS · JOHNS HOPKINS UNIVERSITY · PI MCCALLION, ANDREW S · 2009 to 2018
$4.1MIn Situ Regeneration of Blood VesselR01HL121450 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LI, SONG · 2015 to 2018
$1.8MStem Cells in Vascular RemodelingR01HL117213 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI LI, SONG · 2013 to 2016
$1.4MNEI NIH HHS R01 EY013849NHLBI NIH HHS R01 HL117213NHLBI NIH HHS R01 HL121450NINDS NIH HHS R01 NS062972
Abstract
objectivePrevious genetic lineage tracing studies showed that Sox10 APPROACH AND
resultsUsing genetic lineage tracing technique based on Cre/LoxP system, we examined blood vessels in the adult organs of the mice expressing Sox10-Cre/Rosa-LoxP-red fluorescent protein or Wnt1-Cre/Rosa-LoxP-red fluorescent protein by immunohistological analysis. In addition to previously reported tissues and organs derived from neural crest, we showed that Sox10
conclusionsThis study demonstrates that Sox10
Indexed as
Cell LineageAnimalsFluorescent Antibody TechniqueGenotypeIntegrasesKidneyLuminescent ProteinsLungMice, TransgenicMorphogenesisMuscle, Smooth, VascularMyocytes, Smooth MuscleNeovascularization, PhysiologicNeural CrestPericytesPhenotypeCre recombinaseIntegrasesLuminescent ProteinsRed Fluorescent ProteinSox10 protein, mouseSOXE Transcription FactorsWnt1 ProteinWnt1 protein, mouseblood vesselmousepericytesmooth muscle cellvascular remodeling
Identifiers
What OpenQuestion holds
Textmetadata
LicenceTDM
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.